Commentary: Psychedelic Psychiatry's Brave New World.
Bénédicte Nobile, Emilie Olié, Philippe Courtet
Front Psychiatry November 26, 2020 DOI: 10.3389/fpsyt.2020.594077 (opens in new tab) via PubMed Central
Summary
AI-generated from the abstractThe commentary discusses the emerging field of psychedelic psychiatry, highlighting both its promise for treating mental health conditions and the challenges of integrating these substances into clinical practice. It explores the tension between the transformative potential of psychedelic-assisted therapy and the need for rigorous scientific frameworks, ethical safeguards, and regulatory adaptation. The author argues that while psychedelics may offer new avenues for innovative psychiatry, their adoption requires careful navigation of cultural, legal, and medical landscapes to avoid repeating past mistakes.
Study at a glance
| Characteristics | Commentary Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy |
| Keywords | Mental health treatment Clinical integration Innovative psychiatry |
| Citations | 2 |
| Key finding | Argues that psychedelic psychiatry is at a pivotal juncture requiring balanced optimism and scientific caution. |
Abstract
Commentary: Psychedelic Psychiatry's Brave New World.